Clinical Trial Update: A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC. [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial evaluating toripalimab plus platinum-doublet chemotherapy in locally advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-doublet chemotherapy
• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Locally Advanced NSCLC | Phase 2 | Status: UNKNOWN